US · Healthcare · Health Information Services
EPS came in at 0.14 against a street estimate of 0.16 — a miss of 12.5%.
Analysts rate Doximity Inc a hold (8 buy, 11 hold, 2 sell out of 21) with an average price target of $31.11.
CONFIDENT Doximity beat Q1 FY27 with 7% YoY revenue growth ($157M) and 48% EBITDA margins. AI search launched with strong early traction; Ask won independent NOHARM clinical accuracy study. Company raised full-year guidance $6M on stable pharma environment and AI commercialization momentum. Q1 FY27 Not discussed. Analysts pressed on NOHARM competitive edge (enterprise shift to safety/accuracy), AI search monetization timing (deferred to Q3, deliberate conservative ramp), and pharma budget unlock (new AI+analytics spend vs. cannibalization). Management framed all as long-term TAM expansion with margin-accretive unit economics. 2026-08-06…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 8.03% |
| Vanguard Portfolio Management, LLC | 3.58% |
| Vanguard Capital Management, LLC | 3.35% |
| D. E. Shaw & Co LP | 3.32% |
| Two Sigma Investments LLC | 2.61% |
| State Street Corp | 2.36% |
| The Goldman Sachs Group Inc | 2.29% |
| Geode Capital Management, LLC | 2.16% |
| Document | Date |
|---|---|
| Quarterly report · Q2 FY2027 HEADLINE NUMBERS • For the three months ended September 30, 2026, revenue was $174.537 million, up from $168.525 million in the prior-year quarter. | 2026-11-05 |
| Results announced · Q3 FY2027 HEADLINE NUMBERS • Fiscal 2027 second-quarter revenue was $174.5 million, up 4% year over year from $168.5 million. • GAAP net income was $34.7 mill | 2026-11-05 |
| Shareholder vote results · Q2 FY2027 DOXIMITY, INC. (DOCS) - FORM 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting held August 27, 2026 with 614,551,986 votes represented (96.34% of total | 2026-09-02 |
| Quarterly report · Q1 FY2027 DOXIMITY, INC. – Q1 FY2027 (QUARTER ENDED JUNE 30, 2026) SUMMARY HEADLINE NUMBERS • Revenue: $156.6 million (Q1 2026) vs. $145.9 million (Q1 2025) = | 2026-08-06 |
| Results announced · Q2 FY2027 DOXIMITY, INC. – FISCAL 2027 Q1 RESULTS SUMMARY HEADLINE NUMBERS • Revenue: $156.6 million, up 7% year-over-year (vs. $145.9 million in Q1 FY2026) • | 2026-08-06 |
| Proxy statement · Q2 FY2027 DOXIMITY, INC. – PROXY STATEMENT SUMMARY HEADLINE NUMBERS • Annual Meeting scheduled: August 27, 2026 at 9:00 a.m. Pacific Time (virtual audio-only | 2026-07-15 |
| Annual report FY2026 DOXIMITY, INC. – FORM 10-K SUMMARY (Fiscal Year Ended March 31, 2026) HEADLINE NUMBERS • Market capitalization: $9.86 billion (as of September 30, 2 | 2026-05-19 |
| Results announced · Q1 FY2027 DOXIMITY, INC. – FISCAL YEAR 2026 FINANCIAL SUMMARY HEADLINE NUMBERS • Fiscal Year 2026 Revenue: $644.9 million, up 13% year-over-year (prior year: | 2026-05-13 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Doximity Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.